Luxottica-Essilor Merger to Create Eye-Care Giant
We are leaving our moat ratings and individual valuations unchanged, with both stocks trading in line with our fair value estimates.
On Jan. 16, 2017,
The merger will create a company with EUR 15 billion in revenue, EUR 3.5 billion in EBITDA, and net debt/EBITDA of 0.9 times (as per 2015 results). The combined entity will remain conservatively financed, as no additional debt will be issued concurrently with the merger. Both companies see the benefits of integration in speeding up the supply chain, developing new markets, and combining research and development efforts that would result in a more competitive product offering. There are also revenue and cost synergies to the tune of EUR 400 million-600 million over the medium term and accelerating over the long term. Revenue synergies account for roughly half of the total amount.
The companies expect the merger to close in the second half of 2017, following antitrust and other regulatory and shareholder approvals.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.